J&J opens its wallet with whopping $8.9B talc settlement offer
Fierce Pharma
APRIL 4, 2023
J&J opens its wallet with whopping $8.
Sat.Apr 01, 2023 - Fri.Apr 07, 2023
347 
Pfizer escapes proposed class action lawsuit over patient copay assistance
Fierce Pharma
APRIL 6, 2023
Pfizer escapes proposed class action lawsuit over patient copay assistance esagonowsky Thu, 04/06/2023 - 11:03
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Must know facts about Video marketing in Healthcare
eMediWrite
APRIL 6, 2023
Different types of video media are used in video marketing to advertise and market the goods and services offered by healthcare companies. An astounding 86% of healthcare companies use video marketing as a marketing strategy. The effectiveness of video as a marketing tool is also attributed to its extremely shareable nature. It tries to draw in and educate audiences, hold their attention, and turn them into customers.
The Conversation Around Cancer Costs Must Go Beyond Drugs
MedCity News
APRIL 6, 2023
As a primary care physician and cancer survivor, I’ve seen and experienced the physical and […]
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Eli Lilly Invests Heavily in Debut Mounjaro TV Ad Campaign for Diabetes
PharmExec
APRIL 7, 2023
Eli Lilly debuts its first Mounjaro TV commercial amid high demand for the diabetes injection, which also shows promise in weight loss applications and outperformed rivals Ozempic and Wegovy in clinical trials.
After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits
Fierce Pharma
APRIL 3, 2023
After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits kdunleavy Mon, 04/03/2023 - 06:44
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
The Role of AI in Addressing the Maternal Health Crisis
MedCity News
APRIL 3, 2023
Over 800 women died from pregnancy-related complications in 2020 in the United States, and well […]
Positive results from hVIVO study of Cidara flu candidate
PharmaTimes
APRIL 3, 2023
Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection
FDA authorizes InflaRx's anti-inflammation drug for most serious COVID despite phase 3 miss
Fierce Pharma
APRIL 4, 2023
FDA authorizes InflaRx's anti-inflammation drug for most serious COVID despite phase 3 miss aliu Tue, 04/04/2023 - 16:48
Enanta secures FDA fast track designation for EDP-323 to treat RSV
Pharmaceutical Technology
APRIL 7, 2023
Enanta Pharmaceuticals has secured the US Food and Drug Administration’s (FDA) fast track designation for EDP-323 to treat respiratory syncytial virus (RSV). In vitro data of EDP-323 showed a significant reduction in RSV replication with picomolar potency in primary human bronchial epithelial cells against RSV A and B. Consistent potency was also observed across a range of RSV clinical isolates in several cell types.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
3 Tech Adoption Rules for Health Systems to Follow
MedCity News
APRIL 3, 2023
Hospitals are being more careful than ever when scrutinizing ROI for new technology. Ashis Barad — Allegheny Health Network’s chief information and digital officer — gave advice for health systems follow during the adoption process for new technology, such as ensuring clinicians are involved early on and viewing Big Tech as partners instead of threats.
Eculizumab biosimilar gets positive CHMP opinion
European Pharmaceutical Review
APRIL 6, 2023
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for EPYSQLI , a biosimilar referencing Soliris (eculizumab), also known as SB12. EPYSQLI [has become]… our first biosimilar in haematology to be recommended for approval in Europe” EPYSQLI has been recommended for approval in patients with paroxysmal nocturnal hemoglobinuria (PNH).
GSK will have to pay additional royalties to AstraZeneca on cancer drug Zejula
Fierce Pharma
APRIL 5, 2023
GSK will have to pay additional royalties to AstraZeneca on cancer drug Zejula kdunleavy Wed, 04/05/2023 - 17:03
MHRA fast tracks ADvantage’s immunomodulator for Alzheimer’s disease
Pharmaceutical Technology
APRIL 6, 2023
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted ADvantage Therapeutics’ immunotherapy AD04 an Innovation Passport for the treatment of Alzheimer’s disease. The designation, under the regulator’s Innovative Licensing and Access Pathway (ILAP), will fast-track a potential route to market for AD04 by providing collaborative opportunities with UK institutes like the National Institute for Health and Care Excellence (NICE).
Inato Snags $20M to Make Clinical Trials More Diverse & Accessible
MedCity News
APRIL 2, 2023
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they’re interested.
New Strategies for the Now Everywhere Point of Care
PM360
APRIL 7, 2023
The idea of what constitutes the “point of care” is evolving. At its heart, the point of care has always revolved around the when and where patients are making decisions about their health. Often, these moments are happening in the presence of their healthcare provider (HCP), especially in-person at doctor’s offices. But now patients can also see an HCP via telehealth or chat with them through an online patient portal.
Apellis Pharma and its rare disease, eyecare drugs draw takeover interest: Bloomberg
Fierce Pharma
APRIL 3, 2023
Apellis Pharma and its rare disease, eyecare drugs draw takeover interest: Bloomberg zbecker Mon, 04/03/2023 - 11:00
EC grants marketing authorisation for Sandoz’s biosimilar Hyrimoz
Pharmaceutical Technology
APRIL 3, 2023
The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilar Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF). Hyrimoz has been approved for use in all the indications covered by the reference medicine Humira, including plaque psoriasis, rheumatic diseases, ulcerative colitis, Crohn’s disease, uveitis and hidradenitis suppurativa.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Next Generation of Healthcare Payments: Convenient, Seamless, Simple
MedCity News
APRIL 2, 2023
By supporting next-generation payment methods that boost security and convenience for consumers, providers can enhance patient satisfaction and loyalty.
On Capitol Hill, Humans Battle AI Over Authorship
Copyright Clearance Center
APRIL 7, 2023
The post On Capitol Hill, Humans Battle AI Over Authorship appeared first on Copyright Clearance Center.
Gilead caused injuries while waiting to develop safer HIV drugs, lawsuit claims
Fierce Pharma
APRIL 6, 2023
Gilead caused injuries while waiting to develop safer HIV drugs, lawsuit claims zbecker Thu, 04/06/2023 - 11:40
How Essentials Research Supported Established Brand with Agile Syndicated Tracking
InCrowd
APRIL 6, 2023
A well-known, established blockbuster brand at a top-10 pharma company needed a better solution for tracking its highly competitive market. Their traditional, data-heavy, time-consuming, and expensive ATU wasn’t meeting their needs. Learn how Essentials, InCrowd’s syndicated tracking solution, helped them collect competitive intelligence, save budgetary dollars, and eliminate their large ATU, allowing for more time and attention to the market events.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
3 Key Areas Where Modern Technologies are Accelerating Medtech
MedCity News
APRIL 5, 2023
Consumers are demanding the constant need for technology that is simple, connected and convenient, and medtech companies have had to accelerate to meet those needs. They are embracing these changing times and using it as an opportunity to innovate in three key areas.
Improving Data Quality Through PIDs: How Scholarly Publishers Use Ringgold Solutions
Copyright Clearance Center
APRIL 6, 2023
The post Improving Data Quality Through PIDs: How Scholarly Publishers Use Ringgold Solutions appeared first on Copyright Clearance Center.
AstraZeneca says Lynparza, Imfinzi combo excels in first look at ovarian cancer trial
Fierce Pharma
APRIL 5, 2023
AstraZeneca says Lynparza, Imfinzi combo excels in first look at ovarian cancer trial kdunleavy Wed, 04/05/2023 - 10:46
Vertex and CRISPR Therapeutics submit BLAs to FDA for exa-cel
Pharmaceutical Technology
APRIL 4, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics have completed the rolling submission of biologics licence applications (BLAs) to the US Food and Drug Administration (FDA) for exagamglogene autotemcel (exa-cel) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The applications include requests for priority review. If granted, these would shorten the time taken for application review to eight months.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Regulatory Roundup: Narcan’s Nod, an ALS Adcomm, FDA Holds Lifted & More
MedCity News
APRIL 2, 2023
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
CCC Named to KMWorld 100 Companies That Matter in Knowledge Management for 2023
Copyright Clearance Center
APRIL 5, 2023
The post CCC Named to KMWorld 100 Companies That Matter in Knowledge Management for 2023 appeared first on Copyright Clearance Center.
Amid dispute with FDA, Akebia proposes new dosing for oral anemia drug in kidney disease
Fierce Pharma
APRIL 3, 2023
Amid dispute with FDA, Akebia proposes new dosing for oral anemia drug in kidney disease aliu Mon, 04/03/2023 - 11:12
Sartorius upscales gene therapy prowess with $2.6bn Polyplus acquisition
Pharmaceutical Technology
APRIL 3, 2023
Sartorius , through its French listed sub-group Sartorius Stedim Biotech , has signed an agreement to acquire Polyplus for €2.4bn ($2.6bn). The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. Polyplus, based in Strasbourg, France, produces key components in the production of viral vectors used in cell and gene therapies.
Let's personalize your content